Exacerbation of tumor necrosis factor-induced vascular leak syndrome by aging

被引:1
作者
Park, Kyung-Yeon [1 ]
Kim, Sung-Jo [2 ]
Oh, Euichaul [1 ]
Heo, Tae-Hwe [1 ]
机构
[1] Catholic Univ Korea, Integrated Res Inst Pharmaceut Sci, Coll Pharm, Bucheon, South Korea
[2] Hoseo Univ, Dept Biotechnol, Asan, Chungnam, South Korea
基金
新加坡国家研究基金会;
关键词
Aging; TNF; Vascular leak syndrome; VLS; FACTOR-ALPHA; TNF-ALPHA; ENDOTHELIAL DYSFUNCTION; INFLAMMATION; IMMUNOTHERAPY; CELLS; ATHEROSCLEROSIS; LYMPHOCYTES; ACTIVATION; INDUCTION;
D O I
10.1016/j.biopha.2015.07.041
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aging is associated with upregulation of tumor necrosis factor (TNF) and increased vascular inflammation. TNF is a major proinflammatory cytokine that contributes to both vascular inflammation and vascular leak syndrome (VLS). The purpose of this study was to investigate whether the aging affects TNF-induced VLS. Vascular leak, histology, and cytokine assays were performed in young and aged groups of wild-type and TNF overexpressing transgenic (Tg) mice. An aged group of TNF Tg mice showed substantially amplified VLS compared with young Tg mice. Age-related amplification of TNF-induced VLS appears to be related to local vascular fibrosis and the systemic upregulation of TNF and MCP-1 levels in older TNF Tg mice. Our finding suggests that chronic high-grade TNF exposure could mediate the severe vascular pathogenicity of VLS. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:133 / 137
页数:5
相关论文
共 32 条
[1]   Age-associated impairment in vasorelaxation to fluid shear stress in the female vasculature is improved by TNF-α antagonism [J].
Arenas, IA ;
Xu, Y ;
Davidge, ST .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 290 (03) :H1259-H1263
[2]   Chronic tumor necrosis factor-α inhibition enhances NO modulation of vascular function in estrogen-deficient rats [J].
Arenas, IA ;
Armstrong, SJ ;
Xu, Y ;
Davidge, ST .
HYPERTENSION, 2005, 46 (01) :76-81
[3]   NK cells and polymorphonuclear neutrophils are both critical for IL-2-induced pulmonary vascular leak syndrome [J].
Assier, E ;
Jullien, V ;
Lefort, J ;
Moreau, JL ;
Di Santo, JP ;
Vargaftig, BB ;
Silva, JRLE ;
Thèze, J .
JOURNAL OF IMMUNOLOGY, 2004, 172 (12) :7661-7668
[4]   Vascular leak syndrome: a side effect of immunotherapy [J].
Baluna, R ;
Vitetta, ES .
IMMUNOPHARMACOLOGY, 1997, 37 (2-3) :117-132
[5]  
Baluna R, 1996, CLIN CANCER RES, V2, P1705
[6]   Ageing, tumour necrosis factor-alpha (TNF-α) and atherosclerosis [J].
Bruunsgaard, H ;
Skinhoj, P ;
Pedersen, AN ;
Schroll, M ;
Pedersen, BK .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 121 (02) :255-260
[7]   Neutrophil activation, vascular leak toxicity, and cytolysis during interleukin-2 infusion in human cancer [J].
Carey, PD ;
Wakefield, CH ;
Guillou, PJ .
SURGERY, 1997, 122 (05) :918-926
[8]   Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment [J].
Choy, Ernest ;
Ganeshalingam, Kandeepan ;
Semb, Anne Grete ;
Szekanecz, Zoltan ;
Nurmohamed, Michael .
RHEUMATOLOGY, 2014, 53 (12) :2143-2154
[9]   Clinical targeting of the TNF and TNFR superfamilies [J].
Croft, Michael ;
Benedict, Chris A. ;
Ware, Carl E. .
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (02) :147-168
[10]   Aging-induced proinflammatory shift in cytokine expression profile in rat coronary arteries [J].
Csiszar, A ;
Ungvari, Z ;
Koller, A ;
Edwards, JG ;
Kaley, G .
FASEB JOURNAL, 2003, 17 (06) :1183-+